_id
6919e74d3c536f8df23181e1
Ticker
EKF.LSE
Name
EKF Diagnostics Holdings Plc
Exchange
LSE
Address
Avon House, Cardiff, United Kingdom, CF64 2EZ
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://www.ekfdiagnostics.com
Description
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lactate Scout Sport, a lactate analyzer for sports performance; Biosen series for sports; and EKF Link, a data management solution that integrates point-of-care analyzers. Further, it offers Beta-Hydroxybutyrate LiquiColor for monitoring ketosis; RaPET, a range of immunoassay kits; QuStick Strep A for Strep A infection treatment; Hema-Screen Lab Pack for detection of colorectal cancer; PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA; Uri-Trak 120M urine analyzer; and clinical chemistry reagents, controls, and standards. Additionally, the company provides precision fermentation, custom bioprocessing, and contract manufacturing solutions; and diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Last Close
248000
Volume
13051
Current Price
26.5
Change
2.8225806451612874
Last Updated
2025-12-30T10:50:31.209Z
Image
https://logo.clearbit.com/www.ekfdiagnostics.com
Ipo Date
-
Market Cap
107828696
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
25239000
Cost Of Revenue
12568000
Gross Profit
12671000
Operating Expenses
9183000
Operating Income
3488000
Interest Expense
48000
Pretax Income
3630000
Net Income
1944000
Eps
0.004301344666721593
Dividends Per Share
-
Shares Outstanding
434722112
Income Tax Expense
1530000
EBITDA
5866000
Operating Margin
13.819881928761044
Total Other Income Expense Net
142000
Cash
16616000
Short Term Investments
-
Receivables
7091000
Inventories
7826000
Total Current Assets
31533000
Property Plant Equipment
21875000
Total Assets
82430000
Payables
5791000
Short Term Debt
208000
Long Term Debt
-
Total Liabilities
9550000
Equity
71734000
Bs_currency_symbol
GBP
Depreciation
2188000
Change In Working Capital
-298000
Cash From Operations
4920000
Capital Expenditures
486000
Cash From Investing
-938000
Cash From Financing
-1437000
Net Change In Cash
2315000
Cf_currency_symbol
-
PE
24.8
PB
166.96015610449717
ROE
2.7100119887361642
ROA
2.358364673055926
FCF
4434000
Fcf Percent
0.17568049447283965
Piotroski FScore
4
Health Score
63
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
7.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
7
Net Net Investing Score
4
Quality Investing Score
7
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
25239000
Quarters > 0 > income Statement > cost Of Revenue
12568000
Quarters > 0 > income Statement > gross Profit
12671000
Quarters > 0 > income Statement > operating Expenses
9183000
Quarters > 0 > income Statement > operating Income
3488000
Quarters > 0 > income Statement > interest Expense
48000
Quarters > 0 > income Statement > pretax Income
3630000
Quarters > 0 > income Statement > net Income
1944000
Quarters > 0 > income Statement > eps
0.004301344666721593
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
451951692
Quarters > 0 > income Statement > income Tax Expense
1530000
Quarters > 0 > income Statement > EBITDA
5866000
Quarters > 0 > income Statement > operating Margin
13.819881928761044
Quarters > 0 > income Statement > total Other Income Expense Net
142000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
16616000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7091000
Quarters > 0 > balance Sheet > inventories
7826000
Quarters > 0 > balance Sheet > total Current Assets
31533000
Quarters > 0 > balance Sheet > property Plant Equipment
21875000
Quarters > 0 > balance Sheet > total Assets
82430000
Quarters > 0 > balance Sheet > payables
5791000
Quarters > 0 > balance Sheet > short Term Debt
208000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9550000
Quarters > 0 > balance Sheet > equity
71734000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
1944000
Quarters > 0 > cash Flow > depreciation
2188000
Quarters > 0 > cash Flow > change In Working Capital
-298000
Quarters > 0 > cash Flow > cash From Operations
4920000
Quarters > 0 > cash Flow > capital Expenditures
486000
Quarters > 0 > cash Flow > cash From Investing
-938000
Quarters > 0 > cash Flow > cash From Financing
-1437000
Quarters > 0 > cash Flow > net Change In Cash
2315000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.004301344666721593
Quarters > 0 > ratios > PB
166.96015610449717
Quarters > 0 > ratios > ROE
2.7100119887361642
Quarters > 0 > ratios > ROA
2.358364673055926
Quarters > 0 > ratios > FCF
4434000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.17568049447283965
Quarters > 0 > health Score
63
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
24982000
Quarters > 1 > income Statement > cost Of Revenue
12648000
Quarters > 1 > income Statement > gross Profit
12334000
Quarters > 1 > income Statement > operating Expenses
8918000
Quarters > 1 > income Statement > operating Income
3416000
Quarters > 1 > income Statement > interest Expense
60000
Quarters > 1 > income Statement > pretax Income
3206000
Quarters > 1 > income Statement > net Income
4176000
Quarters > 1 > income Statement > eps
0.009203700017881096
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
453730564
Quarters > 1 > income Statement > income Tax Expense
-1151000
Quarters > 1 > income Statement > EBITDA
5608000
Quarters > 1 > income Statement > operating Margin
13.673845168521334
Quarters > 1 > income Statement > total Other Income Expense Net
-210000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
14301000
Quarters > 1 > balance Sheet > short Term Investments
-1289000
Quarters > 1 > balance Sheet > receivables
6276000
Quarters > 1 > balance Sheet > inventories
7393000
Quarters > 1 > balance Sheet > total Current Assets
28552000
Quarters > 1 > balance Sheet > property Plant Equipment
24034000
Quarters > 1 > balance Sheet > total Assets
81745000
Quarters > 1 > balance Sheet > payables
1297000
Quarters > 1 > balance Sheet > short Term Debt
420000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
8533000
Quarters > 1 > balance Sheet > equity
72327000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
4176000
Quarters > 1 > cash Flow > depreciation
2342000
Quarters > 1 > cash Flow > change In Working Capital
115000
Quarters > 1 > cash Flow > cash From Operations
5791000
Quarters > 1 > cash Flow > capital Expenditures
751000
Quarters > 1 > cash Flow > cash From Investing
-904000
Quarters > 1 > cash Flow > cash From Financing
-7000
Quarters > 1 > cash Flow > net Change In Cash
4481000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.009203700017881096
Quarters > 1 > ratios > PB
166.243034357847
Quarters > 1 > ratios > ROE
5.773777427516695
Quarters > 1 > ratios > ROA
5.1085693314575815
Quarters > 1 > ratios > FCF
5040000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.20174525658474102
Quarters > 1 > health Score
71
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
25212000
Quarters > 2 > income Statement > cost Of Revenue
13150000
Quarters > 2 > income Statement > gross Profit
12062000
Quarters > 2 > income Statement > operating Expenses
9160000
Quarters > 2 > income Statement > operating Income
2902000
Quarters > 2 > income Statement > interest Expense
111000
Quarters > 2 > income Statement > pretax Income
3057000
Quarters > 2 > income Statement > net Income
2066000
Quarters > 2 > income Statement > eps
0.004553363083558991
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
453730564
Quarters > 2 > income Statement > income Tax Expense
837000
Quarters > 2 > income Statement > EBITDA
5550000
Quarters > 2 > income Statement > operating Margin
11.510391876884023
Quarters > 2 > income Statement > total Other Income Expense Net
155000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
9820000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
6733000
Quarters > 2 > balance Sheet > inventories
8157000
Quarters > 2 > balance Sheet > total Current Assets
24710000
Quarters > 2 > balance Sheet > property Plant Equipment
24908000
Quarters > 2 > balance Sheet > total Assets
79327000
Quarters > 2 > balance Sheet > payables
4844000
Quarters > 2 > balance Sheet > short Term Debt
237000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9392000
Quarters > 2 > balance Sheet > equity
68801000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
2066000
Quarters > 2 > cash Flow > depreciation
2382000
Quarters > 2 > cash Flow > change In Working Capital
550000
Quarters > 2 > cash Flow > cash From Operations
7865000
Quarters > 2 > cash Flow > capital Expenditures
1495000
Quarters > 2 > cash Flow > cash From Investing
-1758000
Quarters > 2 > cash Flow > cash From Financing
-4070000
Quarters > 2 > cash Flow > net Change In Cash
2094000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.004553363083558991
Quarters > 2 > ratios > PB
174.76286603392393
Quarters > 2 > ratios > ROE
3.002863330474848
Quarters > 2 > ratios > ROA
2.6044095957240283
Quarters > 2 > ratios > FCF
6370000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.2526574646993495
Quarters > 2 > health Score
66
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
25739000
Quarters > 3 > income Statement > cost Of Revenue
13320000
Quarters > 3 > income Statement > gross Profit
12419000
Quarters > 3 > income Statement > operating Expenses
8741000
Quarters > 3 > income Statement > operating Income
3678000
Quarters > 3 > income Statement > interest Expense
57000
Quarters > 3 > income Statement > pretax Income
2157000
Quarters > 3 > income Statement > net Income
2710000
Quarters > 3 > income Statement > eps
0.005972707626546401
Quarters > 3 > income Statement > dividends Per Share
-5445000
Quarters > 3 > income Statement > shares Outstanding
453730564
Quarters > 3 > income Statement > income Tax Expense
-744000
Quarters > 3 > income Statement > EBITDA
4412000
Quarters > 3 > income Statement > operating Margin
14.289599440537707
Quarters > 3 > income Statement > total Other Income Expense Net
-1521000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
7726000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
8508000
Quarters > 3 > balance Sheet > inventories
8766000
Quarters > 3 > balance Sheet > total Current Assets
25556000
Quarters > 3 > balance Sheet > property Plant Equipment
24775000
Quarters > 3 > balance Sheet > total Assets
80849000
Quarters > 3 > balance Sheet > payables
984000
Quarters > 3 > balance Sheet > short Term Debt
3481000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
12632000
Quarters > 3 > balance Sheet > equity
67117000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
2131000
Quarters > 3 > cash Flow > depreciation
2198000
Quarters > 3 > cash Flow > change In Working Capital
550000
Quarters > 3 > cash Flow > cash From Operations
3805000
Quarters > 3 > cash Flow > capital Expenditures
3492000
Quarters > 3 > cash Flow > cash From Investing
-2218000
Quarters > 3 > cash Flow > cash From Financing
-3046000
Quarters > 3 > cash Flow > net Change In Cash
-1439000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
0.005972707626546401
Quarters > 3 > ratios > PB
179.14775609756097
Quarters > 3 > ratios > ROE
4.03772516650029
Quarters > 3 > ratios > ROA
3.3519276676273053
Quarters > 3 > ratios > FCF
313000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.012160534597303702
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
50194000
Annuals > 0 > income Statement > cost Of Revenue
28714000
Annuals > 0 > income Statement > gross Profit
21480000
Annuals > 0 > income Statement > operating Expenses
15021000
Annuals > 0 > income Statement > operating Income
6459000
Annuals > 0 > income Statement > interest Expense
171000
Annuals > 0 > income Statement > pretax Income
6263000
Annuals > 0 > income Statement > net Income
6242000
Annuals > 0 > income Statement > eps
0.013757063101440087
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
453730564
Annuals > 0 > income Statement > income Tax Expense
-314000
Annuals > 0 > income Statement > EBITDA
11158000
Annuals > 0 > income Statement > operating Margin
12.868071881101326
Annuals > 0 > income Statement > total Other Income Expense Net
-196000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
14301000
Annuals > 0 > balance Sheet > short Term Investments
-1289000
Annuals > 0 > balance Sheet > receivables
6276000
Annuals > 0 > balance Sheet > inventories
7393000
Annuals > 0 > balance Sheet > total Current Assets
28552000
Annuals > 0 > balance Sheet > property Plant Equipment
24034000
Annuals > 0 > balance Sheet > total Assets
81745000
Annuals > 0 > balance Sheet > payables
900000
Annuals > 0 > balance Sheet > short Term Debt
840000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
8533000
Annuals > 0 > balance Sheet > equity
72327000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
6242000
Annuals > 0 > cash Flow > depreciation
4724000
Annuals > 0 > cash Flow > change In Working Capital
665000
Annuals > 0 > cash Flow > cash From Operations
13656000
Annuals > 0 > cash Flow > capital Expenditures
2246000
Annuals > 0 > cash Flow > cash From Investing
-2662000
Annuals > 0 > cash Flow > cash From Financing
-4077000
Annuals > 0 > cash Flow > net Change In Cash
6575000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
0.013757063101440087
Annuals > 0 > ratios > PB
160.72251095275624
Annuals > 0 > ratios > ROE
8.630248731455751
Annuals > 0 > ratios > ROA
7.635941036148999
Annuals > 0 > ratios > FCF
11410000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.22731800613619157
Annuals > 0 > health Score
74
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
52611000
Annuals > 1 > income Statement > cost Of Revenue
28752000
Annuals > 1 > income Statement > gross Profit
23859000
Annuals > 1 > income Statement > operating Expenses
21778000
Annuals > 1 > income Statement > operating Income
2081000
Annuals > 1 > income Statement > interest Expense
75000
Annuals > 1 > income Statement > pretax Income
2131000
Annuals > 1 > income Statement > net Income
2352000
Annuals > 1 > income Statement > eps
0.005179414762202795
Annuals > 1 > income Statement > dividends Per Share
-5445000
Annuals > 1 > income Statement > shares Outstanding
454105359
Annuals > 1 > income Statement > income Tax Expense
-600000
Annuals > 1 > income Statement > EBITDA
7678000
Annuals > 1 > income Statement > operating Margin
3.955446579612629
Annuals > 1 > income Statement > total Other Income Expense Net
50000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
6020000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
6231000
Annuals > 1 > balance Sheet > inventories
8766000
Annuals > 1 > balance Sheet > total Current Assets
25556000
Annuals > 1 > balance Sheet > property Plant Equipment
24775000
Annuals > 1 > balance Sheet > total Assets
80849000
Annuals > 1 > balance Sheet > payables
984000
Annuals > 1 > balance Sheet > short Term Debt
3481000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
12632000
Annuals > 1 > balance Sheet > equity
67117000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
2131000
Annuals > 1 > cash Flow > depreciation
5472000
Annuals > 1 > cash Flow > change In Working Capital
-1049000
Annuals > 1 > cash Flow > cash From Operations
6311000
Annuals > 1 > cash Flow > capital Expenditures
6975000
Annuals > 1 > cash Flow > cash From Investing
-5642000
Annuals > 1 > cash Flow > cash From Financing
-3646000
Annuals > 1 > cash Flow > net Change In Cash
-3852000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
0.005179414762202795
Annuals > 1 > ratios > PB
173.34176583548134
Annuals > 1 > ratios > ROE
3.50432826258623
Annuals > 1 > ratios > ROA
2.909126890870635
Annuals > 1 > ratios > FCF
-664000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.012620934785501131
Annuals > 1 > health Score
49
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
66635000
Annuals > 2 > income Statement > cost Of Revenue
42597000
Annuals > 2 > income Statement > gross Profit
24038000
Annuals > 2 > income Statement > operating Expenses
33009000
Annuals > 2 > income Statement > operating Income
7564000
Annuals > 2 > income Statement > interest Expense
102000
Annuals > 2 > income Statement > pretax Income
-8942000
Annuals > 2 > income Statement > net Income
-10101000
Annuals > 2 > income Statement > eps
-0.022094138194811923
Annuals > 2 > income Statement > dividends Per Share
5459000
Annuals > 2 > income Statement > shares Outstanding
457180086
Annuals > 2 > income Statement > income Tax Expense
634000
Annuals > 2 > income Statement > EBITDA
-2182000
Annuals > 2 > income Statement > operating Margin
11.3513919111578
Annuals > 2 > income Statement > total Other Income Expense Net
-16506000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
11578000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
8585000
Annuals > 2 > balance Sheet > inventories
9434000
Annuals > 2 > balance Sheet > total Current Assets
31761000
Annuals > 2 > balance Sheet > property Plant Equipment
21714000
Annuals > 2 > balance Sheet > total Assets
89291000
Annuals > 2 > balance Sheet > payables
1505000
Annuals > 2 > balance Sheet > short Term Debt
1010000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
14768000
Annuals > 2 > balance Sheet > equity
73346000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-8942000
Annuals > 2 > cash Flow > depreciation
6658000
Annuals > 2 > cash Flow > change In Working Capital
-1716000
Annuals > 2 > cash Flow > cash From Operations
9688000
Annuals > 2 > cash Flow > capital Expenditures
5828000
Annuals > 2 > cash Flow > cash From Investing
-8932000
Annuals > 2 > cash Flow > cash From Financing
-11039000
Annuals > 2 > cash Flow > net Change In Cash
-8763000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.022094138194811923
Annuals > 2 > ratios > PB
159.69451372017562
Annuals > 2 > ratios > ROE
-13.771712158808933
Annuals > 2 > ratios > ROA
-11.312450302942066
Annuals > 2 > ratios > FCF
3860000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.0579275155698957
Annuals > 2 > health Score
32
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
81836000
Annuals > 3 > income Statement > cost Of Revenue
42470000
Annuals > 3 > income Statement > gross Profit
39366000
Annuals > 3 > income Statement > operating Expenses
17619000
Annuals > 3 > income Statement > operating Income
21747000
Annuals > 3 > income Statement > interest Expense
68000
Annuals > 3 > income Statement > pretax Income
21435000
Annuals > 3 > income Statement > net Income
15851000
Annuals > 3 > income Statement > eps
0.034387150419802545
Annuals > 3 > income Statement > dividends Per Share
5103000
Annuals > 3 > income Statement > shares Outstanding
460957067
Annuals > 3 > income Statement > income Tax Expense
5277000
Annuals > 3 > income Statement > EBITDA
27388000
Annuals > 3 > income Statement > operating Margin
26.573879466249572
Annuals > 3 > income Statement > total Other Income Expense Net
-312000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
20341000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
11674000
Annuals > 3 > balance Sheet > inventories
13238000
Annuals > 3 > balance Sheet > total Current Assets
47555000
Annuals > 3 > balance Sheet > property Plant Equipment
17866000
Annuals > 3 > balance Sheet > total Assets
115119000
Annuals > 3 > balance Sheet > payables
4435000
Annuals > 3 > balance Sheet > short Term Debt
1941000
Annuals > 3 > balance Sheet > long Term Debt
431000
Annuals > 3 > balance Sheet > total Liabilities
20377000
Annuals > 3 > balance Sheet > equity
94124000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
21435000
Annuals > 3 > cash Flow > depreciation
5885000
Annuals > 3 > cash Flow > change In Working Capital
-6658000
Annuals > 3 > cash Flow > cash From Operations
10238000
Annuals > 3 > cash Flow > capital Expenditures
5649000
Annuals > 3 > cash Flow > cash From Investing
-5477000
Annuals > 3 > cash Flow > cash From Financing
-6155000
Annuals > 3 > cash Flow > net Change In Cash
-1572000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
0.034387150419802545
Annuals > 3 > ratios > PB
125.46980638880626
Annuals > 3 > ratios > ROE
16.840550762823508
Annuals > 3 > ratios > ROA
13.769230101025896
Annuals > 3 > ratios > FCF
4589000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.056075565765677696
Annuals > 3 > health Score
69
Valuation > metrics > PE
24.8
Valuation > metrics > PB
166.96015610449717
Valuation > final Score
50
Valuation > verdict
2732.7% Overvalued
Profitability > metrics > ROE
2.7100119887361642
Profitability > metrics > ROA
6.164970031395681
Profitability > metrics > Net Margin
0.07702365386901225
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.13313073298575293
Risk > metrics > Interest Coverage
72.66666666666667
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.256376062677113
Liquidity > metrics > Quick Ratio
3.9518253042173694
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
67
Prev Profitabilities > 1
43
Prev Profitabilities > 2
54
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:10.708Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.005
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-15
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0043
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-24
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.01
Earnings History > 2 > eps Estimate
0.008
Earnings History > 2 > eps Difference
0.002
Earnings History > 2 > surprise Percent
25
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-28
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.03
Earnings History > 3 > eps Estimate
0.89
Earnings History > 3 > eps Difference
-0.92
Earnings History > 3 > surprise Percent
-103.3708
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-20
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
1.33
Earnings History > 4 > eps Difference
-1.33
Earnings History > 4 > surprise Percent
-100
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-29
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0.01
Earnings History > 5 > eps Estimate
2.19
Earnings History > 5 > eps Difference
-2.18
Earnings History > 5 > surprise Percent
-99.5434
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-14
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0.02
Earnings History > 6 > eps Estimate
2.19
Earnings History > 6 > eps Difference
-2.17
Earnings History > 6 > surprise Percent
-99.0868
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-22
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.02
Earnings History > 7 > eps Estimate
1.21
Earnings History > 7 > eps Difference
-1.19
Earnings History > 7 > surprise Percent
-98.3471
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-14
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0.01
Earnings History > 8 > eps Estimate
1.17
Earnings History > 8 > eps Difference
-1.16
Earnings History > 8 > surprise Percent
-99.1453
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-24
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0.01
Earnings History > 9 > eps Estimate
0.83
Earnings History > 9 > eps Difference
-0.82
Earnings History > 9 > surprise Percent
-98.7952
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-10
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0.67
Earnings History > 10 > eps Difference
-0.67
Earnings History > 10 > surprise Percent
-100
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-13
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0.02
Earnings History > 11 > eps Estimate
0.66
Earnings History > 11 > eps Difference
-0.64
Earnings History > 11 > surprise Percent
-96.9697
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-19
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0.5
Earnings History > 12 > eps Difference
-0.5
Earnings History > 12 > surprise Percent
-100
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-19
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0.01
Earnings History > 13 > eps Estimate
0.8
Earnings History > 13 > eps Difference
-0.79
Earnings History > 13 > surprise Percent
-98.75
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-09-11
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0.5
Earnings History > 14 > eps Difference
-0.5
Earnings History > 14 > surprise Percent
-100
Earnings History > 15 > period
2017-03-31
Earnings History > 15 > report Date
2017-04-10
Earnings History > 15 > date
2017-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-12
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-03-31
Earnings History > 17 > report Date
2016-04-12
Earnings History > 17 > date
2016-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.03
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2014-06-30
Earnings History > 18 > report Date
2014-09-15
Earnings History > 18 > date
2014-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2013-12-31
Earnings History > 19 > report Date
2014-02-26
Earnings History > 19 > date
2013-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0.12
Earnings History > 19 > eps Difference
-0.12
Earnings History > 19 > surprise Percent
-100
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes; and STAT-Site W Beta-Hydroxybutyrate analyzer. In addition, the company offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; Lactate Scout Vet, a handheld lactate analyzer for veterinary care; Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer; Lactate Scout Sport, a lactate analyzer for sports performance; Biosen series for sports; and EKF Link, a data management solution that integrates point-of-care analyzers. Further, it offers Beta-Hydroxybutyrate LiquiColor for monitoring ketosis; RaPET, a range of immunoassay kits; QuStick Strep A for Strep A infection treatment; Hema-Screen Lab Pack for detection of colorectal cancer; PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA; Uri-Trak 120M urine analyzer; and clinical chemistry reagents, controls, and standards. Additionally, the company provides precision fermentation, custom bioprocessing, and contract manufacturing solutions; and diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEKF Diagnostics (LON:EKF) Stock Crosses Below 200-Day Moving Average - Here's Why - MarketBeat
1/21/2026
EKF Diagnostics (LON:EKF) Stock Crosses Below 200-Day Moving Average - Here's Why MarketBeat
Read more →EKF Diagnostics and Its Healthcare Operations Across FTSE AIM Landscape Kalkine Media
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of EKF Diagnostics Holdings Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.005
Date
2025-06-30
EPS Actual
0.0043
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.